We believe that the use of MACC1 protein, as examined by IHC, as a diagnostic biomarker of HCC could improve the prospects of the early detection of HCC, and that an improved rate of detection would have important prognostic implications for patients with HCC. This evidence concerns the gene MACC1 and hepatocellular carcinoma.